DOV Pharmaceutical to acquire remaining stake in formulations joint venture from Elan Corporation - MarketLine Financial Deals

DOV Pharmaceutical to acquire remaining stake in formulations joint venture from Elan Corporation

DOV Pharmaceutical to acquire remaining stake in formulations joint venture from Elan Corporation - MarketLine Financial Deals
DOV Pharmaceutical to acquire remaining stake in formulations joint venture from Elan Corporation
Published Oct 22, 2003
3 pages — Published Oct 22, 2003
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

DOV Pharmaceutical, Inc., a US-based biopharmaceutical company, has agreed to acquire the remaining stake in a joint venture operating company established in 1999 to develop controlled release formulations of bicifadine and ocinaplon.

  
Source:
Document ID
MA88751_111124
Country
Country
Ticker
DOVP=US
Ticker
ELN=IE
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "DOV Pharmaceutical to acquire remaining stake in formulations joint venture from Elan Corporation" Oct 22, 2003. Alacra Store. Dec 07, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/DOV-Pharmaceutical-to-acquire-remaining-stake-in-formulations-joint-venture-from-Elan-Corporation-2052-73292>
  
APA:
MarketLine Financial Deals. (2003). DOV Pharmaceutical to acquire remaining stake in formulations joint venture from Elan Corporation Oct 22, 2003. New York, NY: Alacra Store. Retrieved Dec 07, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/DOV-Pharmaceutical-to-acquire-remaining-stake-in-formulations-joint-venture-from-Elan-Corporation-2052-73292>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.